Coronavirus vaccine based upon tobacco could begin human trials next month
INSUBCONTINENT EXCLUSIVE:
British American Tobacco biotech subsidiary, Kentucky BioProcessing (KBP), uses tobacco plants to make the vaccine, which is derived from
the genetic sequence of SARS-CoV-2
